Tag: Antibody

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very ...

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit ...

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy ...

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most ...

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in ...

New AI-driven tool converts common histology images into detailed, multi-layered cancer markers, promising faster, more accurate diagnostics and improved patient ...

Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health ...

The research article presents a comprehensive evaluation of the human epidermal growth factor receptor 2 (HER2) status in extramammary Paget ...

The body has a veritable army constantly on guard to keep us safe from microscopic threats from infections to cancer. ...